Matthew Kacsmaryk
American judge
Follow Matthew Kacsmaryk on Notably News to receive short updates to your email — rarely!
| June 13 2024 | Supreme Court of the United States unanimously lifted his injunction, restoring access to mifepristone under current FDA regulations. |
| 2023 | During his Senate confirmation process, Matthew Kacsmaryk faced controversy for failing to disclose two Christian talk radio interviews where he discussed sensitive social issues including religious freedom, anti-discrimination legislation, abortion, and contraception. |
| 2023 | CNN reported that Matthew Kacsmaryk had concealed significant financial information on his 2020 and 2021 financial disclosures, specifically redacting the name of a company in which he owned between $5 million and $25 million in stock. |
| April 21 2023 | The Supreme Court voted to indefinitely implement an emergency stay on all restrictions against mifepristone while the lawsuit continued in lower courts. |
| April 13 2023 | A three-judge panel of the United States Court of Appeals for the Fifth Circuit granted an emergency stay on Kacsmaryk's restriction, partially modifying his original ruling on mifepristone. |
| April 7 2023 | Kacsmaryk issued a preliminary ruling suspending the FDA's approval of mifepristone, a significant and controversial decision in the abortion medication debate. |
| March 2023 | First hearing held for the Alliance for Hippocratic Medicine v. FDA lawsuit challenging mifepristone's FDA approval. |
| November 2022 | Kacsmaryk ruled that the Biden administration violated the Administrative Procedure Act by interpreting the Affordable Care Act to prohibit discrimination based on sexual orientation and gender identity. |
| November 2022 | Alliance Defending Freedom filed a lawsuit in Kacsmaryk's federal district challenging the FDA's 2000 approval of mifepristone, a medication abortion drug. |
| 2021 | Kacsmaryk ordered the reinstatement of the 'Remain in Mexico' policy, requiring asylum seekers to wait outside U.S. territory while their claims are processed. This decision was later overturned by the Supreme Court on June 30, 2022. |
| June 21 2019 | Kacsmaryk received his judicial commission, officially becoming a United States district judge for the Northern District of Texas. |
| June 19 2019 | Kacsmaryk's nomination was confirmed by the Senate with a 52–46 vote. |
| June 18 2019 | The Senate invoked cloture on Kacsmaryk's nomination by a 52–44 vote. |
| February 7 2019 | Kacsmaryk's nomination was reported out of committee by a 12–10 vote. |
| January 23 2019 | President Trump announced his intent to renominate Kacsmaryk for a federal judgeship. |
| January 3 2019 | Kacsmaryk's nomination was again returned to President Trump under Senate Rule XXXI, Paragraph 6. |
| January 18 2018 | Kacsmaryk's nomination was reported out of committee by an 11–10 vote. |
| January 5 2018 | President Trump announced his intent to renominate Kacsmaryk to a federal judgeship. |
| January 3 2018 | Kacsmaryk's initial nomination was returned to the president under Senate Rule XXXI, Paragraph 6. |
| 2017 | During his judicial nomination, Kacsmaryk's financial disclosures revealed ownership of approximately $2.9 million in stock in Publix, a Florida-based supermarket chain. |
| December 13 2017 | A Senate Judiciary Committee hearing was held regarding Kacsmaryk's judicial nomination. |
| September 7 2017 | President Donald Trump nominated Matthew Kacsmaryk to serve as a United States district judge for the Northern District of Texas, filling the seat vacated by judge Mary Lou Robinson. |
| April 2017 | Kacsmaryk requested his Texas Review of Law and Politics editor to remove his name from the article, citing unspecified reasons and suggesting co-authorship with First Liberty colleagues. |
| April 11 2017 | Kacsmaryk emailed an editor a draft of an article titled 'MJK First Draft' about physicians with religious objections to treating transgender patients or performing abortions. |
| March 2017 | Kacsmaryk was under consideration for a judicial nomination, meeting with Texas Senators Ted Cruz and John Cornyn, as well as White House Counsel. |
| 2015 | Submitted an amicus brief to the Supreme Court arguing against a Washington law mandating pharmacies provide contraceptives. |
| 2014 | Started working for the conservative Christian legal organization First Liberty Institute. |
| 2013 | Received the attorney general's award for excellence in furthering the interests of U.S. national security for his work in United States v. Aldawsari. |
| 2013 | Concluded his tenure as a federal prosecutor in Texas. |
| 2012 | Became a member of the Fort Worth chapter of the Federalist Society. |
This contents of the box above is based on material from the Wikipedia article Matthew Kacsmaryk, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.